Stage IVA Prostate Cancer AJCC v8 Withdrawn Phase 2 Trials for Gallium-68 PSMA (DB16303)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05034562Gallium-68 PSMA-11 PET in Participants With Prostate CancerDiagnostic